CP
Camelot Portfolios’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-79
| Closed | -$5.42K | – | 313 |
|
2024
Q2 | $5.42K | Buy |
+79
| New | +$5.42K | ﹤0.01% | 465 |
|
2023
Q1 | – | Sell |
-3,356
| Closed | -$288K | – | 184 |
|
2022
Q4 | $288K | Sell |
3,356
-2,261
| -40% | -$194K | 0.21% | 132 |
|
2022
Q3 | $347K | Sell |
5,617
-1,597
| -22% | -$98.7K | 0.33% | 93 |
|
2022
Q2 | $446K | Buy |
7,214
+1,849
| +34% | +$114K | 0.27% | 112 |
|
2022
Q1 | $319K | Sell |
5,365
-3,356
| -38% | -$200K | 0.16% | 167 |
|
2021
Q4 | $633K | Buy |
8,721
+857
| +11% | +$62.2K | 0.26% | 128 |
|
2021
Q3 | $549K | Sell |
7,864
-1,211
| -13% | -$84.5K | 0.28% | 107 |
|
2021
Q2 | $625K | Buy |
+9,075
| New | +$625K | 0.25% | 120 |
|
2016
Q2 | – | Sell |
-5,815
| Closed | -$534K | – | 173 |
|
2016
Q1 | $534K | Buy |
5,815
+3,291
| +130% | +$302K | 0.33% | 79 |
|
2015
Q4 | $255K | Sell |
2,524
-45
| -2% | -$4.55K | 0.16% | 121 |
|
2015
Q3 | $252K | Hold |
2,569
| – | – | 0.17% | 126 |
|
2015
Q2 | $301K | Buy |
2,569
+329
| +15% | +$38.5K | 0.17% | 125 |
|
2015
Q1 | $220K | Sell |
2,240
-5,935
| -73% | -$583K | 0.13% | 148 |
|
2014
Q4 | $771K | Buy |
+8,175
| New | +$771K | 0.44% | 70 |
|